Gold nanoparticles conjugated with DNA aptamer for photoacoustic detection of human matrix metalloproteinase-9
Affiliations
a Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA 30332, USA
b School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta. GA 30332, USA
Abstract
Matrix metalloproteinase-9 (MMP-9) plays major roles in extracellular matrix (ECM) remodeling and membrane protein cleavage, suggesting a high correlation with cancer cell invasion and tumor metastasis. Here, we present a contrast agent based on a DNA aptamer that can selectively target human MMP-9 in the tumor microenvi-ronment (TME) with high affinity and sensitivity. Surface modification of plasmonic gold nanospheres with the MMP-9 aptamer and its complementary sequences allows the nanospheres to aggregate in the presence of human MMP-9 through DNA displacement and hybridization. Aggregation of gold nanospheres enhances the optical absorption in the first near-infrared window (NIR-I) due to the plasmon coupling effect, thereby allowing us to detect the aggregated gold nanospheres within the TME via ultrasound-guided photoacoustic (US/PA) imaging. Selective and sensitive detection of human MMP-9 via US/PA imaging is demonstrated in solution of nanosensors with the pre-treatment of human MMP-9, in vitro in cell culture, and in vivo in a xenograft murine model of human breast cancer.
Reference
[1] C.E. Brinckerhoff, L.M. Matrisian, Timeline – matrix metalloproteinases: a tail of a frog that became a prince, Nat. Rev. Mol. Cell Biol. 3 (3) (2002) 207–214.
[2] A. Page-McCaw, A.J. Ewald, Z. Werb, Matrix metalloproteinases and the regulation of tissue remodelling, Nat. Rev. Mol. Cell Biol. 8 (3) (2007) 221–233.
[3] H. Huang, Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: recent advances, Sensors 18 (10) (2018) 3249.
[4] J. Cathcart, A. Pulkoski-Gross, J. Cao, Targeting matrix metalloproteinases in cancer: bringing new life to old ideas, Genes Dis. 2 (1) (2015) 26–34.
[5] A. Winer, S. Adams, P. Mignatti, Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes, Mol. Cancer Ther. 17 (6) (2018) 1147–1155.
[6] H.C. Schunk, D.S. Hernandez, M.J. Austin, K.S. Dhada, A.M. Rosales, L.J. Suggs, Assessing the range of enzymatic and oxidative tunability for biosensor design,
J. Mater. Chem. B 8 (16) (2020) 3460–3487.
[7] V. Lukacova, Y. Zhang, M. Mackov, P. Baricic, S. Raha, J.A. Calvo, S. Balaz, Similarity of binding sites of human matrix metalloproteinases, J. Biol. Chem. 279
(14) (2004) 14194–14200.
[8] A.B.E. Attia, G. Balasundaram, M. Moothanchery, U.S. Dinish, R. Bi,
V. Ntziachristos, M. Olivo, A review of clinical photoacoustic imaging: current and future trends, Photoacoustics 16 (2019), 100144.
[9] C.L. Bayer, G.P. Luke, S.Y. Emelianov, Photoacoustic imaging for medical diagnostics, Acoust. Today 8 (4) (2012) 15–23.
[10] K.P. Kubelick, S.Y. Emelianov, Prussian blue nanocubes as a multimodal contrast agent for image -guided stem cell therapy of the spinal cord, Photoacoustics 18 (2020), 100166.
[11] G.P. Luke, D. Yeager, S.Y. Emelianov, Biomedical applications of photoacoustic imaging with exogenous contrast agents, Ann. Biomed. Eng. 40 (2) (2012) 422–437.
[12] K.S. Dhada, D.S. Hernandez, W.B. Huang, L.J. Suggs, Gold nanorods as photoacoustic nanoprobes to detect proinflammatory macrophages and inflammation, ACS Appl. Nano Mater. 3 (8) (2020) 7774–7780.
[13] Y.S. Chen, Y. Zhao, S.J. Yoon, S.S. Gambhir, S. Emelianov, Miniature gold nanorods for photoacoustic molecular imaging in the second near-infrared optical window, Nat. Nanotechnol. 14 (5) (2019) 465–472.
[14] P.P. Joshi, S.J. Yoon, W.G. Hardin, S. Emelianov, K.V. Sokolov, Conjugation of antibodies to gold nanorods through Fc portion: synthesis and molecular specific imaging, Bioconjugate Chem. 24 (6) (2013) 878–888.
[15] W. Li, X. Chen, Gold nanoparticles for photoacoustic imaging, Nanomedicine 10
(2) (2015) 299–320.
[16] J.N. Anker, W.P. Hall, O. Lyandres, N.C. Shah, J. Zhao, R.P. Van Duyne, Biosensing with plasmonic nanosensors, Nat. Mater. 7 (6) (2008) 442–453.
[17] S. Mallidi, T. Larson, J. Tam, P.P. Joshi, A. Karpiouk, K. Sokolov, S. Emelianov, Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer, Nano Lett. 9 (8) (2009) 2825–2831.
[18] S.Y. Nam, L.M. Ricles, L.J. Suggs, S.Y. Emelianov, Nonlinear photoacoustic signal increase from endocytosis of gold nanoparticles, Opt. Lett. 37 (22) (2012) 4708–4710.
[19] S.K. Ghosh, T. Pal, Interparticle coupling effect on the surface plasmon resonance of gold nanoparticles: From theory to applications, Chem. Rev. 107 (11) (2007) 4797–4862.
[20] C. Sonnichsen, B.M. Reinhard, J. Liphardt, A.P. Alivisatos, A molecular ruler based on plasmon coupling of single gold and silver nanoparticles, Nat. Biotechnol. 23 (6) (2005) 741–745.
[21] C. Tabor, D. Van Haute, M.A. El-Sayed, Effect of orientation on plasmonic coupling between gold nanorods, ACS Nano 3 (11) (2009) 3670–3678.
[22] J. Nam, N. Won, H. Jin, H. Chung, S. Kim, pH-induced aggregation of gold nanoparticles for photothermal cancer therapy, J. Am. Chem. Soc. 131 (38) (2009) 13639–13645.
[23] A. Sanchez-Iglesias, M. Grzelczak, T. Altantzis, B. Goris, J. Perez-Juste, S. Bals,
G. Van Tendeloo, S.H. Donaldson Jr., B.F. Chmelka, J.N. Israelachvili, L.M. Liz- Marzan, Hydrophobic interactions modulate self-assembly of nanoparticles, ACS Nano 6 (12) (2012) 11059–11065.
Q. Zeng, R. Marthi, A. McNally, C. Dickinson, T.E. Keyes, R.J. Forster, Host-guest directed assembly of gold nanoparticle arrays, Langmuir 26 (2) (2010) 1325–1333. J. Kim, C. Jo, W.G. Lim, S. Jung, Y.M. Lee, J. Lim, H. Lee, J. Lee, W.J. Kim, Programmed nanoparticle-loaded nanoparticles for deep-penetrating 3D cancer therapy, Adv. Mater. 30 (29) (2018), 1707557.
[26] J. Kim, Y.M. Lee, Y. Kang, W.J. Kim, Tumor-homing, size-tunable clustered nanoparticles for anticancer therapeutics, ACS Nano 8 (9) (2014) 9358–9367.
[27] H. Park, J. Kim, S. Jung, W.J. Kim, DNA-Au nanomachine equipped with i-Motif and G-Quadruplex for triple combinatorial anti-tumor therapy, Adv. Funct. Mater. 28 (5) (2018), 1705416.
[28] Y.J. Chen, B. Groves, R.A. Muscat, G. Seelig, DNA nanotechnology from the test tube to the cell, Nat. Nanotechnol. 10 (9) (2015) 748–760.
[29] J. Kim, D. Jang, H. Park, S. Jung, D.H. Kim, W.J. Kim, Functional-DNA-driven dynamic nanoconstructs for biomolecule capture and drug delivery, Adv. Mater. 30
(45) (2018), 1707351.
[30] H. Lee, J. Kim, J. Lee, H. Park, Y. Park, S. Jung, J. Lim, H.C. Choi, W.J. Kim, In vivo self-degradable graphene nanomedicine operated by DNAzyme and photo-switch for controlled anticancer therapy, Biomaterials 263 (2020), 120402.
[31] R. Stoltenburg, C. Reinemann, B. Strehlitz, SELEX – a (r)evolutionary method to generate high-affinity nucleic acid ligands, Biomol. Eng. 24 (4) (2007) 381–403.
[32] A.D. Keefe, S. Pai, A. Ellington, Aptamers as therapeutics, Nat. Rev. Drug Discov. 9
(7) (2010) 537–550.
[33] S. Scarano, E. Dausse, F. Crispo, J.J. Toulme, M. Minunni, Design of a dual aptamer-based recognition strategy for human matrix metalloproteinase 9 protein by piezoelectric biosensors, Anal. Chim. Acta 897 (2015) 1–9.
[34] J. Kim, J. Park, H. Kim, K. Singha, W.J. Kim, Transfection and intracellular trafficking properties of carbon dot-gold nanoparticle molecular assembly conjugated with PEI-pDNA, Biomaterials 34 (29) (2013) 7168–7180.
[35] Z. Zhai, X. Qu, H. Li, Z. Ouyang, W. Yan, G. Liu, X. Liu, Q. Fan, T. Tang, K. Dai,
A. Qin, Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression, Mol. Med. Rep. 11 (2) (2015) 1139–1145.
[36] J. Liu, Y. Lu, Preparation of aptamer-linked gold nanoparticle purple aggregates for colorimetric sensing of analytes, Nat. Protoc. 1 (1) (2006) 246–252.
[37] M.W. Roomi, J.C. Monterrey, T. Kalinovsky, M. Rath, A. Niedzwiecki, Patterns of MMP-2 and MMP-9 expression in human cancer cell lines, Oncol. Rep. 21 (5) (2009) 1323–1333.
[38] W.J. Akers, B. Xu, H. Lee, G.P. Sudlow, G.B. Fields, S. Achilefu, W.B. Edwards, Detection of MMP-2 and MMP-9 activity in vivo with a triple-helical peptide optical probe, Bioconjugate Chem. 23 (3) (2012) 656–663.
[39] J. Levi, S.R. Kothapalli, S. Bohndiek, J.K. Yoon, A. Dragulescu-Andrasi, C. Nielsen,
J. Yang, Z. Zhang, J. Lin, J. Lu, B.F. Liu, S. Zeng, Q. Luo, Detection of MMP activity in living cells by a genetically encoded surface-displayed FRET sensor, Biochim. Biophys. Acta 1773 (3) (2007) 400–407.
C. Moore, R.M. Borum, Y. Mantri, M. Xu, P. Fajtova, A.J. O’Donoghue, J.V. Jokerst, Activatable carbocyanine dimers for photoacoustic and fluorescent detection of protease activity, ACS Sens. 6 (6) (2021) 2356–2365.